PRISM BioLab and Receptor.AI Partner for AI Drug Discovery
TOKYO, Japan & CAMBRIDGE, Mass., March 13, 2026 PRISM BioLab Co., Ltd. and Receptor.AI Inc. have announced a strategic...
Alzheimer’s Disease Animal Health Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cell Therapy cGxP cGxP compliance Clinical-Stage Biotech Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy GMP compliance Immuno-Oncology immunology Immunotherapy Johnson & Johnson Medical Devices MedTech medtech innovation Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine Regulatory Affairs regulatory approval regulatory compliance Sanofi targeted therapy
Vaccines, Blood & Biologics
TOKYO, Japan & CAMBRIDGE, Mass., March 13, 2026 PRISM BioLab Co., Ltd. and Receptor.AI Inc. have announced a strategic...
CAMBRIDGE, Mass., March 11, 2026 Vima Therapeutics has announced a major milestone in its drug development pipeline, confirming that...
KING OF PRUSSIA, Pa., March 9, 2026 CSL Limited, a global biopharmaceutical leader, has announced a $1.5 billion investment...
SEATTLE — March 11, 2026 Aminex Therapeutics, a clinical-stage biotechnology company focused on developing treatments for rare and difficult-to-treat...
SECAUCUS, N.J. — March 12, 2026 Pierre Fabre Pharmaceuticals announced that the U.S. Food and Drug Administration has agreed...
PALO ALTO, CA — March 11, 2026 BridgeBio Pharma announced that its investigational therapy BBP-418 demonstrated consistent efficacy and...
WALTHAM, Mass. — March 11, 2026 Pretzel Therapeutics announced new preclinical data for its lead therapeutic candidate PX578 during...
Ashburn, Virginia — March 9, 2026 Clinical-stage specialty biopharmaceutical company Quoin Pharmaceuticals Ltd. continues to advance the development of...
Beerse, Belgium — March 10, 2026 Global healthcare company Johnson & Johnson has announced the submission of a Type...
Lund, Sweden – March 10, 2026 Alligator Bioscience, a clinical-stage biotechnology company focused on tumor-directed immuno-oncology therapies, has announced...
